News Agency
Men's Weekly

Abivax: ABX464 inhibits replication of SARS-CoV-2 (COVID-19) in reconstituted human respiratory epithelium model

  • Written by Media Outreach

ABX464 is the only drug candidate with a potential triple action for COVID-19 treatment: antiviral, anti-inflammatory and tissue repair

 

  • ABX464, as assessed by RTqPCR, inhibits in vitro viral replication of SARS-CoV-2 (COVID-19)
  • Simultaneously, Abivax receives ANSM and CPP clearance[1] to test ABX464 as promising COVID-19 therapeutic candidate...

Read more: Abivax: ABX464 inhibits replication of SARS-CoV-2 (COVID-19) in reconstituted human respiratory...

Maximising Brand Visibility with Vehicle Signage and Truck Signage

In a world where competition for consumer attention is fierce, businesses are constantly looking for innovative ways to market their products and services. One of the most powerful methods is turning vehicles into moving billboards with professional vehicle signage and... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion